Monocacy Therapeutics Inc. develops artificial intelligence-guided, first-in-class immune medicines designed to restore optimal immune function and patient health. The company utilizes a full-stack, AI-powered immunology platform to discover and develop next-generation immunotherapies for patients.
Subscribe to see Monocacy Therapeutics Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Monocacy Therapeutics Inc. is a biotechnology company headquartered in United States. It has raised at least $414,450 across the 3 funding rounds on record. Its most recent funding round, Seed, raised $150,000 in July 2026. Xcout tracks 2 named people at Monocacy Therapeutics Inc., including Shashank Patel (Executive Officer).
As of 16 November 2026. Source: Xcout Intel.
At least $414,450 raised across the 3 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Seed | $150,000 | — | |
| Grant | $150,000 | 1 named | |
| Seed | $114,450 | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of Monocacy Therapeutics Inc.'s closest competitors — see the full list of competitors and alternatives →
Matchpoint Therapeutics is a privately held biotechnology company based in Watertown, Massachusetts, focused on advancing a pipeline of first-in-class oral small molecules for autoimmune and inflammatory diseases.
immunitoAI is a TechBio research company founded in 2020 that develops AI-driven platforms to unlock the potential of antibody therapeutics. Headquartered in Bengaluru, Karnataka, India, the company employs a team of 11 to 50 professionals.
Auransa is a clinical-stage, AI-native biopharmaceutical company headquartered in Palo Alto, California. It utilizes a proprietary artificial intelligence platform to mine massive human disease datasets for discovering novel therapeutics.
Noetik Inc. is an AI-native biotechnology company headquartered in South San Francisco, California, leveraging advanced machine learning methods for biological discovery.
Prellis Biologics, Inc. is a privately held biotechnology company headquartered in Berkeley, California, within the San Francisco Bay Area. It develops human antibody therapeutics and focuses on antibody discovery leveraging AI and immune diversity.
Lunai Bioworks Inc. (LNAI), formerly operating as Renovaro, is now dedicated to leveraging artificial intelligence for the creation of advanced medical treatments and the strengthening of biological defense systems. A significant project currently underway is the development of its specialized "Neurotoxicity Intelligence Technology."
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Monocacy Therapeutics Inc.? Suggest a correction · Work at Monocacy Therapeutics Inc.? Claim this profile
Post the link and the card appears automatically — each network fetches the image itself.